What is the Anrep effect (Anrepathing effect)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

The Anrep effect is a cardiac compensatory mechanism where the heart maintains its stroke volume despite an increase in afterload, achieved through a two-phase activation of resting myosin for contraction, involving strain-sensitive and posttranslational phases, as recently described in the study by 1. This mechanism is crucial for maintaining cardiac output when faced with increased resistance in the circulatory system. The Anrep effect is characterized by an initial decrease in stroke volume, followed by an increase in cardiac contractility within 1-2 minutes, which helps to restore output. Some key points about the Anrep effect include:

  • It is an intrinsic adaptation of the heart muscle itself, independent of neural or hormonal influences, as noted in the study by 2.
  • The effect is named after Russian physiologist Gleb von Anrep, who first described this phenomenon in the early 20th century.
  • The Anrep effect is closely related to the Frank-Starling law, which describes the heart's ability to adjust to changing mechanical loads, as discussed in the study by 3.
  • Recent studies, such as the one by 4, have shed light on the molecular mechanisms underlying the Anrep effect, including the role of Ca2+/calmodulin-dependent protein kinase II (CaMKII) activity and oxidative stress.
  • The Anrep effect has important implications for our understanding of cardiac physiology and pathophysiology, particularly in conditions such as hypertrophic cardiomyopathy, as highlighted in the study by 1.
  • The effect is characterized by a unique signature, including enhanced contractility and a prolonged systolic ejection time, which can be detected using noninvasive echocardiographic pressure-volume measurements, as demonstrated in the study by 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.